Cargando…
Zoledronate/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions
The pathophysiology, pathogenesis, histopathology, and immunopathology of medication-related osteonecrosis of the jaw (MRONJ) Stage 0 remain unclear, although 50% of MRONJ Stage 0 cases could progress to higher stages. The aim of this study was to investigate the effects of zoledronate (Zol) and ant...
Autores principales: | Kaneko, Haruka, Kuroshima, Shinichiro, Kozutsumi, Ryohei, Al-Omari, Farah A., Hayano, Hiroki, Nakajima, Kazunori, Sawase, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004236/ https://www.ncbi.nlm.nih.gov/pubmed/36902701 http://dx.doi.org/10.3390/jcm12051914 |
Ejemplares similares
-
Role of Osteal Macrophages in Bone Metabolism
por: Cho, Sun Wook
Publicado: (2015) -
Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review
por: Kawahara, Mampei, et al.
Publicado: (2021) -
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
por: Kuroshima, Shinichiro, et al.
Publicado: (2019) -
Pleural nodule with osteal protrusion anterior to the rib tubercle: a case report
por: Kusakabe, Masashi, et al.
Publicado: (2021) -
Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ
por: Roato, Ilaria, et al.
Publicado: (2023)